(Q38934537)

7 September 2017

title

Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells (English)

1 reference

7 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Christopher A Tormey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Manjula Santhanakrishnan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Nicole H Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Jingchun Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Susanne Marschner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Jeanne E Hendrickson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

8 December 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

863-872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26643781%20AND%20SRC:MED&resulttype=core&format=json

The safety of the blood supply--time to raise the bar.

8 June 2020

cites work

1 reference

Clinical trials for pathogen reduction in transfusion medicine: a review

21 January 2018

1 reference

Pathogen-reduction systems for blood components: the current position and future trends

21 January 2018

1 reference

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

21 January 2018

1 reference

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

21 January 2018

1 reference

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products

21 January 2018

1 reference

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood

21 January 2018

1 reference

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

21 January 2018

1 reference

Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment

21 January 2018

1 reference

Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products

21 January 2018

1 reference

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

21 January 2018

1 reference

White blood cell inactivation after treatment with riboflavin and ultraviolet light

21 January 2018

1 reference

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

21 January 2018

1 reference

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice

21 January 2018

1 reference

Functional inactivation of white blood cells by Mirasol treatment.

21 January 2018

1 reference

WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization

21 January 2018

1 reference

Predictors of red cell alloimmunization in multitransfused Egyptian patients with β-thalassemia

21 January 2018

1 reference

HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial.

21 January 2018

1 reference

Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.

21 January 2018

1 reference

Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

21 January 2018

1 reference

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

21 January 2018

1 reference

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

21 January 2018

1 reference

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

21 January 2018

1 reference

Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen

21 January 2018

1 reference

Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity.

21 January 2018

1 reference

Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope

21 January 2018

1 reference

Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

21 January 2018

1 reference

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants

21 January 2018

1 reference

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model

21 January 2018

1 reference

Immunological behavior of enhanced green fluorescent protein (EGFP) as a minor histocompatibility antigen with a special reference to skin isograft and specific regulation of local graft-versus-host reaction (GvHR).

21 January 2018

1 reference

Immune response to green fluorescent protein: implications for gene therapy

21 January 2018

1 reference